SEC Form 4 · accession 0001800668-26-000007
Revolution Medicines, Inc. · RVMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jack Anders
Officer — Chief Financial Officer
Period of report
Sep 16, 2026
Accepted (ET)
Sep 18, 2026 · 6:00 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001628171
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 16, 2026 | S | 61 | $195.00 | D | 123,208 | D | |
| Common StockF2 | Sep 16, 2026 | S | 3,992 | $199.3032 | D | 119,216 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units.
- F2Includes 43,650 restricted stock units.